SCHEMBL6974237

SCHEMBL6974237

COc1ccc(Cn2cnc(Cc3ccccc3)c2)cc1.N=CN

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.51
CDK5R1 Q15078 1/20 0.51
LTA4H P09960 1/20 0.47
CYP19A1 P11511 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
HPGD P15428 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6955809 0.85 HPGDS (0.39) CYP19A1SIGMAR1CYP11B1CYP11B2ALDH1A1
SCHEMBL6973877 0.84 CYP3A4 (0.45) LTA4HCYP19A1CYP11B1CYP11B2POLB
SCHEMBL6972535 0.82 KDM4C (0.38) POLBL3MBTL1CYP3A4CYP2D6CYP2C9
SCHEMBL30741761 0.80 HPGDS (0.50) CDK5CDK5R1CYP19A1SIGMAR1CYP11B1
SCHEMBL6952807 0.76 SIGMAR1 (0.45) CYP19A1SIGMAR1CYP11B1CYP11B2ALDH1A1
SCHEMBL6965586 0.74 THRB (0.39) LTA4HCYP19A1CYP11B1CYP11B2HTT
SCHEMBL6972346 0.74 PHF8 (0.38) CDK5CDK5R1CYP19A1SIGMAR1ALDH1A1
SCHEMBL4840104 0.73 HPGDS (0.58) CDK5CDK5R1SIGMAR1CYP11B1CYP11B2
SCHEMBL5755079 0.73 NPC1 (0.60) CDK5CDK5R1CYP19A1CYP11B1NPC1
SCHEMBL13824975 0.73 CDK5 (0.46) CDK5CDK5R1CYP19A1CYP11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729459-B1 PHENYL-ALKYL IMIDAZOLES AS H3-RECEPTOR ANTAGONISTS SCHERING CORP (US) 2003-03-12 EP disclosed
US-5578616-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, TREATMENT FOR GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS SCHERING CORPORATION (US) 1996-11-26 US disclosed